Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA

<p>Abstract</p> <p>Background</p> <p>In the American region, Puerto Rico (PR) has the highest incidence of oral and pharyngeal cancer (OPC), but racial/ethnic differences have never been assessed and compared with other groups in the United States of America (USA). We compared the age-adjusted incidence and mortality rates of OPC between PR and among USA Hispanics (USH), Non-Hispanic Whites (NHW), and Non-Hispanic Blacks (NHB) to assess the burden of this cancer in PR.</p> <p>Methods</p> <p>Analysis of the age-standardized rates (per 100,000) was performed using the direct method with the world standard population (ASR(World)) from 1998–2002. Annual percent change (APC) and Relative Risks (RR) were calculated using the Poisson regression model.</p> <p>Results</p> <p>The incidence ASR(World) for men in PR was constant (APC ≈ 0.0%), in contrast, a decrease was observed among NHW, NHB, and USH men, although only USH showed statistical significance (APC = -4.9%, p < 0.05). In women, the highest increase in incidence (APC = 5.3%) and the lowest decrease in mortality (APC = -1.4%) was observed in PR. The ratio of the ASR(World) showed that in all racial/ethnic groups, men had approximately 2–4 fold increased incidence and mortality risk of OPC than women (p < 0.05). Men in PR had a higher mortality risk (p < 0.05) of OPC as compared to USH, NHW, and NHB; but among women, PR showed a significant excess of mortality only as compared to USH (est. SRR = 1.82, 95% CI = 1.41, 2.33).</p> <p>Conclusion</p> <p>The overall higher incidence of OPC in men in PR as compared to USH, NHB, and NHW could be explained by the effect of gene-environment interactions. Meanwhile, the higher mortality from OPC in PR suggests limitations in the health-care access within this population. Further research is warranted to elucidate these findings.</p

Anurans from the Lower Cretaceous Jehol Group of western Liaoning, China

BACKGROUND: To date, the Lower Cretaceous Jehol Group of western Liaoning, China has yielded five monotypic genera of anurans, including Liaobatrachus grabaui, Callobatrachus sanyanensis, Mesophryne beipiaoensis, Dalianbatrachus mengi, and Yizhoubatrachus macilentus. However, the validity and distinctness of these taxa have been questioned. METHODOLOGY/PRINCIPAL FINDING: We provide a comprehensive analysis of the Jehol frogs that includes a re-examination of the published taxa as well as an examination of a number of new specimens that have been collected over the past 10 years. The results show that the five previously named taxa can be referred to three species of one genus-Liaobatrachus grabaui, L. beipiaoensis comb. nov. and L. macilentus comb. nov.. The diagnosis of Liaobatrachus is revised, and a new diagnosis is provided for each species of this genus. We also establish Liaobatrachus zhaoi sp. nov., on the basis of a dozen well-preserved specimens from a new locality. This taxon is distinguished by a unique combination of characteristics, including relatively long hind limbs, a rounded rather than triangular acetabulum, and a gradually-tapering cultriform process of the parasphenoid. In addition, an unnamed frog from a higher horizon, which has narrow sacral diapophyses and particularly long legs, is different from Liaobatrachus and represents another form of anuran in the Jehol Biota. CONCLUSION/SIGNIFICANCE: Comparisons with other Mesozoic and extant anurans and the primary phylogenetic analysis both suggest that Liaobatrachus is a member of the anuran crown-group and forms a polytomy with leiopelmatids (Ascaphus and Leiopelma) and the remaining crown-group anurans (Lalagobatrachia).Liping Dong, Zbyněk Roček, Yuan Wang, Marc E H. Jone

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)

Carmen D Zorrilla,1 Fiorella Reyes B&aacute;ez,1 Karolyn Gonz&aacute;lez Col&oacute;n,2 Jessica Ibarra,2 Iris Garc&iacute;a,2 Ana M Mosquera2 1Obstetrics and Gynecology Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico; 2Maternal Infant Studies Center (CEMI), Obstetrics and Gynecology Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico Abstract: The reduction in the mother-to-infant transmission of HIV has been among the early successes of care and treatment of women living with HIV. Prenatal HIV counseling and testing, the availability of diverse antiretroviral therapies, elective cesarean section, and the use of formula milk have significantly reduced the mother-to-infant transmission in the USA and Europe. We are presenting two cases of seroconversion during pregnancy, identified during labor and delivery, of women who received risk reduction counseling and serial HIV testing during pregnancy. Because there are no guidelines for (or easy access to) the use of pre-exposure prophylaxis (PrEP) in pregnancy, they were offered other strategies for prevention including risk reduction counseling, condoms, and serial HIV testing. These cases support the use of PrEP during pregnancy. Both infants were negative and the women are currently receiving long-term highly active antiretroviral therapy. One of them recently delivered another infant. After these two women seroconverted, we decided to offer PrEP to all pregnant women presenting for care who report having an HIV positive partner. During the period 2012&ndash;2014, we treated ten HIV negative pregnant women who were partners of HIV positive men. Since 2015, we have seen 20 pregnant women in HIV discordant relationships. Of those, seven received PrEP. No seroconversions have been observed among the pregnant women on PrEP. Although small numbers, seroconversion during pregnancy was observed in two of 13 (15%) of the pregnant women in HIV-discordant relationships seen in our clinic, excluding those treated with PrEP. Given the safety data and experience with tenofovir and emtricitabine among pregnant women living with HIV, we believe PrEP should be offered in pregnancy and that guidelines should reflect this option as an additional strategy to reduce risks during pregnancy and to further reduce infant HIV transmission risk. Keywords: PrEP, pregnancy, HIV, HIV seroconversio

Nearly tight bounds for testing function isomorphism

We study the problem of testing isomorphism (equivalence up to relabelling of the variables) of two Boolean functions f, g: {0, 1} n → {0, 1}. Our main focus is on the most studied case, where one of the functions is given (explicitly) and the other function may be queried. We prove that for every k ≤ n, the worst-case query complexity of testing isomorphism to a given k-junta is Ω(k) and O(k log k). Consequently, the query complexity of testing function isomorphism is e Θ(n). Prior to this work, only lower bounds of Ω(log k) queries were known, for limited ranges of k, proved by Fischer et al. (FOCS 2002), Blais and O’Donnell (CCC 2010), and recently by Alon and Blais (RANDOM 2010). The nearly tight O(k log k) upper bound improves on the e O(k 4) upper bound from Fischer et al. (FOCS 2002). Extending the lower bound proof, we also show polynomial query-complexity lower bounds for the problems of testing whether a function can be computed by a circuit of size ≤ s, and testing whether the Fourier degree of a function is ≤ d. This answers questions posed by Diakonikolas et al. (FOCS 2007). We also address two closely related problems – 1. Testing isomorphism to a k-junta with one-sided error: we prove that for any 1 &lt; k &lt; n − 1, the query complexity is Ω(log ` ´ n), which is almost optimal. Thi